From: Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes
Patient | Age | Sex | Oxygen saturation | Injury* | GCS | ISS | GOSE |
---|---|---|---|---|---|---|---|
1 | 23 | M | Normoxic | 4 | 7 | 33 | 4 |
2 | 19 | M | Normoxic | 1 | 8 | 30 | 5 |
3 | 50 | M | Hypoxic | 1 | 5 | 41 | 4 |
4 | 33 | M | Normoxic | 4 | 4 | 38 | 1 |
5 | 40 | M | Normoxic | 6 | 7 | 21 | 6 |
6 | 33 | M | Hypoxic | 2 | 3 | 43 | 4 |
7 | 21 | F | Normoxic | 1 | 7 | 21 | 3 |
8 | 26 | F | Hypoxic | 6 | 3 | 45 | 3 |
9 | 22 | M | Normoxic | 5 | 7 | 30 | 5 |
10 | 35 | M | Hypoxic | 6 | 4 | 45 | 5 |
11 | 25 | M | Hypoxic | 1 | 4 | 41 | N.A. |
12 | 47 | M | Normoxic | 4 | 7 | 29 | 3 |
13 | 26 | M | Normoxic | 1 | 8 | 34 | |
14 | 29 | F | Hypoxic | 1 | 5 | 38 | 5 |
15 | 20 | M | Normoxic | 4 | 3 | 21 | 3 |
16 | 48 | F | Hypoxic | 8 | 3 | 34 | 1 |
17 | 22 | M | Normoxic | 1 | 8 | 34 | |
18 | 24 | M | Hypoxic | 1 | 3 | 34 | 5 |
19 | 19 | M | N.A. | N.A. | N.A. | N.A. | N.A. |
20 | 31 | M | Hypoxic | 1 | 5 | 43 | 2 |
21 | 39 | M | Normoxic | 6 | 7 | 26 | 8 |
22 | 25 | F | Hypoxic | 1 | 3 | 35 | 3 |
23 | 52 | F | Normoxic | 4 | 6 | 43 | 1 |
24 | 36 | M | Normoxic | 4 | 3 | 29 | 3 |
25 | 58 | M | Normoxic | 3 | 7 | 50 | 5 |
26 | 25 | M | Normoxic | 6 | 8 | 17 | 1 |
Control 1 | 42 | M | Normoxic | ||||
Control 2 | 80 | M | Normoxic | ||||
Control 3 | 56 | M | Normoxic |